z-logo
open-access-imgOpen Access
Colorectal cancer patients with liver metastases and severe hyperbilirubinemia: A consecutive series that explores the benefits and risks of chemotherapy
Author(s) -
Aminah Jatoi
Publication year - 2008
Publication title -
therapeutics and clinical risk management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.719
H-Index - 55
eISSN - 1178-203X
pISSN - 1176-6336
DOI - 10.2147/tcrm.s3951
Subject(s) - medicine , oxaliplatin , colorectal cancer , chemotherapy , bilirubin , regimen , gastroenterology , cancer , oncology
Do colorectal cancer patients with hyperbilirubinemia and liver metastases benefit from chemotherapy?

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom